ELUTIA INC.

ELUTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$12.3M

▼ 15.0% YoY

Net Income

$53.4M

▲ 198.9% YoY

EPS

$0.87

▲ 146.8% YoY

Cash

$36.4M

▲ 174.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.